Value of a risk scoring tool to predict respiratory syncytial virus disease severity and need for hospitalization in term infants

Journal of Medical Virology

Volumn 87, Issue 8, 2015, Pages 1285-1291

  Mosalli, Rafat ^a   Abdul Moez, Asmaa Mostafa ^b   Janish, Mohammed ^b   Paes, Bosco ^c  

^a UMM AL QURA UNIVERSITY   (Saudi Arabia)

^b International Medical Center   (Saudi Arabia)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Respiratory syncytial virus; Risk scoring tool; Severity; Term infants

Indexed keywords

ARTICLE; ASSISTED VENTILATION; CHILD HOSPITALIZATION; CONVENIENCE SAMPLE; DISEASE SEVERITY; FEMALE; HOSPITALIZED INFANT; HUMAN; INFANT; KRISTJANSSON CLINICAL RESPIRATORY SCORE; LENGTH OF STAY; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PILOT STUDY; PREDICTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT DISEASE ASSESSMENT; RETROSPECTIVE STUDY; RISK SCORING TOOL; SCORING SYSTEM; VIRAL BRONCHIOLITIS; DECISION SUPPORT SYSTEM; HOSPITALIZATION; NEWBORN; PATHOLOGY; PROGNOSIS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SEVERITY OF ILLNESS INDEX;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

DECISION SUPPORT TECHNIQUES; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; PILOT PROJECTS; PROGNOSIS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84930370420     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24189     Document Type: Article

References (37)

1. Blanken MO, Koffijberg H, Nibbelke EE, Rovers MM, Bont L. Dutch RSV Neonatal Network. 2013. Prospective validation of a prognostic model for respiratory syncytial virus bronchiolitis in late preterm infants: A multicenter birth cohort study. PLoS ONE 8:e59161.
2. Blyth CC, Booy R, Dwyer DE. 2011. Point of care testing: Diagnosis outside the virology laboratory. Methods Mol Biol 665:415-433.
3. Bont L, Houben ML. 2011. Commentary: Why are young healthy term infants protected against respiratory syncytial virus bronchiolitis? Pediatr Infect Dis J 30:785-786.
4. Butt ML, Symington A, Janes M, Elliott L, Steele S, Paes BA. 2011. The impact of prophylaxis on paediatric intensive care unit admissions for RSV infection: A retrospective, single-centre study. Eur J Pediatr 170:907-913.
5. Chin HJ, Seng QB. 2004. Reliability and validity of the respiratory score in the assessment of acute bronchiolitis. Malays J Med Sci 11:34-40.
6. Feng L, Li Z, Zhao S, Nair H, Lai S, Xu W, Li M, Wu J, Ren L, Liu W, Yuan Z, Chen Y, Wang X, Zhao Z, Zhang H, Li F, Ye X, Li S, Feikin D, Yu H, Yang W. 2014. Viral etiologies of hospitalized acute lower respiratory infection patients in China, 2009-2013. PLoS ONE 9:e99419.
7. Figueras-Aloy J, Carbonell-Estrany X, Quero J. IRIS Study Group. 2004. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain. Pediatr Infect Dis J 23:815-820.
8. Figueras-Aloy J, Carbonell-Estrany X, Quero-Jiménez J, Fernández-Colomer B, Guzmán-Cabañas J, Echaniz-Urcelay I. Doménech-Martínez E; IRIS Study Group. 2008. FLIP-2 Study: Risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks. Pediatr Infect Dis J 27:788-793.
9. Frogel M, Nerwen C, Cohen A, VanVeldhuisen P, Harrington M, Boron M. Palivizumab Outcomes Registry Group. 2008. Prevention of hospitalization due to respiratory syncytial virus: Results from the Palivizumab Outcomes Registry. J Perinatol 28:511-517.
10. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, Grijalva CG, Zhu Y, Szilagyi P. 2009. The burden of respiratory syncytial virus infection in young children. N Engl J Med 360:588-598.
11. Hasegawa K, Mansbach JM, Teach SJ, Fisher ES, Hershey D, Koh JY, Clark S, Piedra PA, Sullivan AF, Camargo CA, Jr. 2014. Multicenter study of viral etiology and relapse in hospitalized children with bronchiolitis. Pediatr Infect Dis J 33:809-813.
12. Heikkinen T, Valkonen H, Lehtonen L, Vainionpää R, Ruuskanen O. 2005. Hospital admission of high risk infants for respiratory syncytial virus infection: Implications for palivizumab prophylaxis. Arch Dis Child Fetal Neonatal Ed 90:F64-F68.
13. Horn SD, Smout RJ. 2003. Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes. J Pediatr 143:S133-S141.
14. Houben ML, Bont L, Wilbrink B, Belderbos ME, Kimpen JL, Visser GH, Rovers MM. 2011. Clinical prediction rule for RSV bronchiolitis in healthy newborns: prognostic birth cohort study. Pediatrics 127:35-41.
15. Kristjánsson S, Lødrup Carlsen KC, Wennergren G, Strannegård IL, Carlsen KH. 1993. Nebulised racemic adrenaline in the treatment of acute bronchiolitis in infants and toddlers. Arch Dis Child 69:650-654.
16. Kusuda S, Takahashi N, Saitoh T, Terai M, Kaneda H, Kato Y, Ohashi A, Watabe S, Joh-o K, Hirai K. 2011. Survey of pediatric ward hospitalization due to respiratory syncytial virus infection after the introduction of palivizumab to high-risk infants in Japan. Pediatr Int 53:368-373.
17. Lanctôt KL, Masoud ST, Paes BA, Tarride JE, Chiu A, Hui C, Francis PL, Oh PI. 2008. The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32-35 weeks: A Canadian-based analysis. Curr Med Res Opin 24:3223-3237.
18. Langley JM, Wang EE, Law BJ, Stephens D, Boucher FD, Dobson S, McDonald J, MacDonald NE, Mitchell I, Robinson JL. 1997. Economic evaluation of respiratory syncytial virus infection in Canadian children: a Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study. J Pediatr 131:113-117.
19. Langley GF, Anderson LJ. 2011. Epidemiology and prevention of respiratory syncytial virus infections among infants and young children. Pediatr Infect Dis J 30:510-517.
20. Law BJ, Langley JM, Allen U, Paes B, Lee DS, Mitchell I, Sampalis J, Walti H, Robinson J, O'Brien K, Majaesic C, Caouette G, Frenette L, Le Saux N, Simmons B, Moisiuk S, Sankaran K, Ojah C, Singh AJ, Lebel MH, Bacheyie GS, Onyett H, Michaliszyn A, Manzi P, Parison D. 2004. The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J 23:806-814.
21. Makari D, Hoopes JM, White N. 2009. Impact of RSV: Implications for managed care. Manag Care 18:2-7.
22. Mansbach JM, Piedra PA, Teach SJ, Sullivan AF, Forgey T, Clark S, Espinola JA, Camargo CA, Jr. MARC-30 Investigators. 2012. Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med 166:700-706.
23. Miron D, Srugo I, Kra-Oz Z, Keness Y, Wolf D, Amirav I, Kassis I. 2010. Sole pathogen in acute bronchiolitis: Is there a role for other organisms apart from respiratory syncytial virus? Pediatr Infect Dis J 29:e7-e10.
24. Moreno-Perez D, Calvo C. Five Study Group. 2014. Epidemiological and clinical data of hospitalizations associated with respiratory syncytial virus infection in children under 5 years of age in Spain: FIVE multicenter study. Influenza Other Respir Viruses 8:209-216.
25. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O'Brien KL, Roca A, Wright PF, Bruce N, Chandran A, Theodoratou E, Sutanto A, Sedyaningsih ER, Ngama M, Munywoki PK, Kartasasmita C, Simões EA, Rudan I, Weber MW, Campbell H. 2010. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: A systematic review and meta-analysis. Lancet 375:1545-1555.
26. Navas L, Wang E, de Carvalho V, Robinson J. 1992. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. J Pediatr 121:348-354.
27. Paes B, Cole M, Latchman A, Pinelli J. 2009. Predictive value of the respiratory syncytial virus risk-scoring tool in the term infant in Canada. Curr Med Res Opin 25:2191-2196.
28. Paes BA, Mitchell I, Banerji A, Lanctôt KL, Langley JM. 2011. A decade of respiratory syncytial virus epidemiology and prophylaxis: Translating evidence into everyday clinical practice. Can Respir J 18:e10-e19.
29. Paes B, Mitchell I, Li A, Harimoto T, Lanctôt KL. 2013. Respiratory-related hospitalizations following prophylaxis in the Canadian registry for palivizumab (2005-2012) compared to other international registries. Clin Dev Immunol 2013:917068.
30. Prais D, Danino D, Schonfeld T, Amir J. 2005. Impact of palivizumab on admission to the ICU for respiratory syncytial virus bronchiolitis: A national survey. Chest 128:2765-2771.
31. Rudan I, O'Brien KL, Nair H, Liu L, Theodoratou E, Qazi S, Lukšić I, Fischer Walker CL, Black RE, Campbell H. Child Health Epidemiology Reference Group (CHERG). 2013. Epidemiology and etiology of childhood pneumonia in 2010: Estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health 3:010401.
32. Sampalis JS, Langley J, Carbonell-Estrany X, Paes B, O'Brien K, Allen U, Mitchell I, Aloy JF, Pedraz C, Michaliszyn AF. 2008. Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation. Med Decis Making 28:471-480.
33. Simões EA, Carbonell-Estrany X, Fullarton JR, Liese JG, Figueras-Aloy J, Doering G, Guzman J. European RSV Risk Factor Study Group. 2008. A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study. Respir Res 9:78.
34. Simões EA, Mutyara K, Soh S, Agustian D, Hibberd ML, Kartasasmita CB. 2011. The epidemiology of respiratory syncytial virus lower respiratory tract infections in children less than 5 years of age in Indonesia. Pediatr Infect Dis J 30:778-784.
35. Sommer C, Resch B, Simões EA. 2011. Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiol J 5:144-154.
36. Thorburn K. 2009. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child 94:99-103.
37. Willson DF, Landrigan CP, Horn SD, Smout RJ. 2003. Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia. J Pediatr 143:S142-S149.